月経痛とは、下腹部の強いけいれん性の痛みのことです。多くの女性が生理の直前や生理中に生理痛を経験します。子宮内膜症や子宮筋腫などの病気が原因で起こることもあります。月経痛の症状には、下腹部のズキズキした痛みやけいれん性の痛み、腰や太ももの痛みなどがあります。また、吐き気、緩い便、頭痛、めまいを経験する女性もいます。
世界の月経痛治療市場の成長は、女性の月経痛患者の増加による月経痛治療に対する需要の増加が主な要因です。また、月経痛治療に対する意識の高まりが、月経痛治療市場の成長をさらに後押ししています。しかし、月経痛治療に関する知識の不足や、吐き気、便秘、嘔吐といった月経痛治療の副作用が市場成長の妨げとなっています。逆に、新興市場における成長機会と世界的な支出の急増は、市場プレーヤーに有利な機会を提供すると予想されます。
生理痛治療市場は、種類、治療法、流通チャネル、地域に区分されます。種類別では、市場は原発性月経困難症と続発性月経困難症に分類されます。治療薬別では、市場は非ステロイド性抗炎症薬とホルモン療法に分別されます。流通チャネル別では、市場は病院薬局、ドラッグストア・小売薬局、オンラインプロバイダーに分類されます。地域別では、北米(米国、カナダ、メキシコ)、欧州(ドイツ、フランス、英国、イタリア、スペイン、その他欧州)、アジア太平洋(日本、中国、オーストラリア、インド、韓国、その他アジア太平洋)、LAMEA(ブラジル、南アフリカ、サウジアラビア、その他LAMEA)に市場を分けて分析しています。
世界の月経痛治療市場で事業を展開する主な主要企業は、Abbott Laboratories, AbbVie Inc., Bayer AG, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Limited, Torrent Pharmaceuticalsです。
〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの月経痛治療市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、月経痛治療市場の有力な市場機会を特定します。
・市場調査は、主要な促進要因、阻害要因、機会に関する情報とともに提供されます。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・月経痛治療市場の細分化に関する詳細な分析により、市場機会を見極めます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・月経痛治療の地域別および世界市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。
〈主要市場セグメント〉
種類別
原発性月経困難症
二次性月経困難症
治療法別
非ステロイド性抗炎症薬
ホルモン療法
流通チャネル別
病院薬局
ドラッグストア&小売薬局
オンラインプロバイダー
地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
インド
オーストラリア
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域
〈主要市場プレイヤー〉
AbbVie Inc.
Bayer AG
Johnson and Johnson
Taj Pharmaceuticals Limited
Torrent Pharmaceuticals Ltd.
Abbott Laboratories
Dr. Reddy’s Laboratories Ltd.
Pfizer Inc.
GlaxoSmithKline plc
Sun Pharmaceutical Industries Ltd.
TABLE 1. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 2. MENSTRUAL CRAMPS TREATMENT MARKET FOR PRIMARY DYSMENORRHEA, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. MENSTRUAL CRAMPS TREATMENT MARKET FOR PRIMARY DYSMENORRHEA, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 4. MENSTRUAL CRAMPS TREATMENT MARKET FOR SECONDARY DYSMENORRHEA, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. MENSTRUAL CRAMPS TREATMENT MARKET FOR SECONDARY DYSMENORRHEA, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 6. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 7. MENSTRUAL CRAMPS TREATMENT MARKET FOR NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. MENSTRUAL CRAMPS TREATMENT MARKET FOR NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 9. MENSTRUAL CRAMPS TREATMENT MARKET FOR HORMONAL THERAPY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. MENSTRUAL CRAMPS TREATMENT MARKET FOR HORMONAL THERAPY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 11. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 12. MENSTRUAL CRAMPS TREATMENT MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. MENSTRUAL CRAMPS TREATMENT MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 14. MENSTRUAL CRAMPS TREATMENT MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. MENSTRUAL CRAMPS TREATMENT MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 16. MENSTRUAL CRAMPS TREATMENT MARKET FOR ONLINE PROVIDERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. MENSTRUAL CRAMPS TREATMENT MARKET FOR ONLINE PROVIDERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 18. MENSTRUAL CRAMPS TREATMENT MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. NORTH AMERICA MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 20. NORTH AMERICA MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 21. NORTH AMERICA MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 22. NORTH AMERICA MENSTRUAL CRAMPS TREATMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 23. U.S. MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 24. U.S. MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 25. U.S. MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 26. CANADA MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 27. CANADA MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 28. CANADA MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 29. MEXICO MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 30. MEXICO MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 31. MEXICO MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 32. EUROPE MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 33. EUROPE MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 34. EUROPE MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 35. EUROPE MENSTRUAL CRAMPS TREATMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 36. GERMANY MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 37. GERMANY MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 38. GERMANY MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 39. FRANCE MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 40. FRANCE MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 41. FRANCE MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 42. UK MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 43. UK MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 44. UK MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 45. ITALY MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. ITALY MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 47. ITALY MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 48. SPAIN MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. SPAIN MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 50. SPAIN MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 51. REST OF EUROPE MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 52. REST OF EUROPE MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 53. REST OF EUROPE MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 54. ASIA-PACIFIC MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 55. ASIA-PACIFIC MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 56. ASIA-PACIFIC MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 57. ASIA-PACIFIC MENSTRUAL CRAMPS TREATMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 58. JAPAN MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 59. JAPAN MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 60. JAPAN MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 61. CHINA MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. CHINA MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 63. CHINA MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 64. INDIA MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. INDIA MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 66. INDIA MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 67. AUSTRALIA MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 68. AUSTRALIA MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 69. AUSTRALIA MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 70. SOUTH KOREA MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 71. SOUTH KOREA MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 72. SOUTH KOREA MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 73. REST OF ASIA-PACIFIC MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 74. REST OF ASIA-PACIFIC MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 75. REST OF ASIA-PACIFIC MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 76. LAMEA MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 77. LAMEA MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 78. LAMEA MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 79. LAMEA MENSTRUAL CRAMPS TREATMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 80. BRAZIL MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 81. BRAZIL MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 82. BRAZIL MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 83. SAUDI ARABIA MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 84. SAUDI ARABIA MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 85. SAUDI ARABIA MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 86. SOUTH AFRICA MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 87. SOUTH AFRICA MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 88. SOUTH AFRICA MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 89. REST OF LAMEA MENSTRUAL CRAMPS TREATMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 90. REST OF LAMEA MENSTRUAL CRAMPS TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
TABLE 91. REST OF LAMEA MENSTRUAL CRAMPS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
TABLE 92.ABBVIE INC.: COMPANY SNAPSHOT
TABLE 93.ABBVIE INC.: OPERATING SEGMENTS
TABLE 94.ABBVIE INC.: PRODUCT PORTFOLIO
TABLE 95.ABBVIE INC.: NET SALES
TABLE 96.ABBVIE INC.: KEY STRATERGIES
TABLE 97.BAYER AG: COMPANY SNAPSHOT
TABLE 98.BAYER AG: OPERATING SEGMENTS
TABLE 99.BAYER AG: PRODUCT PORTFOLIO
TABLE 100.BAYER AG: NET SALES
TABLE 101.BAYER AG: KEY STRATERGIES
TABLE 102.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 103.JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 104.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 105.JOHNSON AND JOHNSON: NET SALES
TABLE 106.JOHNSON AND JOHNSON: KEY STRATERGIES
TABLE 107.TAJ PHARMACEUTICALS LIMITED: COMPANY SNAPSHOT
TABLE 108.TAJ PHARMACEUTICALS LIMITED: OPERATING SEGMENTS
TABLE 109.TAJ PHARMACEUTICALS LIMITED: PRODUCT PORTFOLIO
TABLE 110.TAJ PHARMACEUTICALS LIMITED: NET SALES
TABLE 111.TAJ PHARMACEUTICALS LIMITED: KEY STRATERGIES
TABLE 112.TORRENT PHARMACEUTICALS LTD.: COMPANY SNAPSHOT
TABLE 113.TORRENT PHARMACEUTICALS LTD.: OPERATING SEGMENTS
TABLE 114.TORRENT PHARMACEUTICALS LTD.: PRODUCT PORTFOLIO
TABLE 115.TORRENT PHARMACEUTICALS LTD.: NET SALES
TABLE 116.TORRENT PHARMACEUTICALS LTD.: KEY STRATERGIES
TABLE 117.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 118.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 119.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 120.ABBOTT LABORATORIES: NET SALES
TABLE 121.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 122.DR. REDDY'S LABORATORIES LTD.: COMPANY SNAPSHOT
TABLE 123.DR. REDDY'S LABORATORIES LTD.: OPERATING SEGMENTS
TABLE 124.DR. REDDY'S LABORATORIES LTD.: PRODUCT PORTFOLIO
TABLE 125.DR. REDDY'S LABORATORIES LTD.: NET SALES
TABLE 126.DR. REDDY'S LABORATORIES LTD.: KEY STRATERGIES
TABLE 127.GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 128.GLAXOSMITHKLINE PLC: OPERATING SEGMENTS
TABLE 129.GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 130.GLAXOSMITHKLINE PLC: NET SALES
TABLE 131.GLAXOSMITHKLINE PLC: KEY STRATERGIES
TABLE 132.PFIZER INC.: COMPANY SNAPSHOT
TABLE 133.PFIZER INC.: OPERATING SEGMENTS
TABLE 134.PFIZER INC.: PRODUCT PORTFOLIO
TABLE 135.PFIZER INC.: NET SALES
TABLE 136.PFIZER INC.: KEY STRATERGIES
TABLE 137.SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
TABLE 138.SUN PHARMACEUTICAL INDUSTRIES LTD.: OPERATING SEGMENTS
TABLE 139.SUN PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 140.SUN PHARMACEUTICAL INDUSTRIES LTD.: NET SALES
TABLE 141.SUN PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/